Blood marker for blood vessel health in sleep apnea with obesity
Part of Heart & circulation, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at a blood marker called adropin to see if it relates to the health of your blood vessels and the severity of your sleep apnea. It may help doctors better understand and monitor these conditions in patients who are obese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 75 years old.
- You must be obese and have confirmed sleep apnea (diagnosed by a sleep study).
- You must not be pregnant.
- You must be willing to have your blood drawn for testing.
- You must be able to temporarily stop certain medications (like statins or ACE inhibitors) if needed, under medical supervision.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.
This study looks at how body fat (“adipose tissue”) may differ in people with obstructive sleep apnea. You may be asked for consent and could be asked to stop certain medicines short-term so researchers can take a safe fat sample.
This study looks at whether certain markers in sleep apnea patients can predict how well they will stick with CPAP (a mask that helps you breathe at night). If you're newly diagnosed and about to start CPAP, this could help personalize your care.
This study looks at whether sleep apnea (a condition where you stop breathing during sleep) might be linked to problems in the tiny blood vessels of the heart. By doing a sleep study and a heart scan, we hope to find ways to better diagnose and treat these heart issues.
This trial is studying tiny molecules in the blood (called microRNAs) to see if they can help diagnose or monitor obstructive sleep apnea. It compares people with moderate to severe sleep apnea who are starting PAP therapy with people who do not have sleep apnea.
This Phase 1 study looks at how blood vessel function is affected by obstructive sleep apnea in adults who are newly diagnosed and have not used CPAP. It may help researchers understand the early effects of sleep apnea and guide future treatments.
Hear when a new Adropin In Patients of OSA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.